Science doesn’t always reach the clinic in a straight line.
A biomarker discovered in the lab still needs to be measured, tested, validated and assessed before it can assist a clinical decision.
The VIROMARKERS project brings pharmaceutical and diagnostic companies, researchers, clinicians, community representatives and regulatory bodies into the same working group, researching on biomarkers for HIV, hepatitis Delta, CMV and TTV infections.
On World Science Day for Peace and Development, we celebrate the collaboration that helps move scientific research from the laboratory into clinical care to support people.
